1. Archives
  2. Magazine - 05 Apr 2018

  3. Destiny Pharma targets $1bn US market with anti-microbial resistant drug

The company’s anti-infective XF-73 could have the potential to kill bacteria within 15 minutes

|Feature|by Lisa-Marie Janes
< How to use past performance figures wisely
Phoenix could be the best income stock you’ve never heard of >
Issue: 05 Apr 2018 - Page 45 |
Contents
Next:
Phoenix could be the best income stock you’ve never heard of
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJ Bell logo
Lisa-Marie Janes profile pic
Lisa-Marie Janes

Issue Contents

Most Read

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of directors' buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
21 Nov 2024 Subscribe now

Market Overview

UK 350 Risers and Fallers